Mailbox medicine: simple letters aim to slash dangerous drug use in Alzheimer's patients
NCT ID NCT06368115
Summary
This study tested whether sending educational mail to caregivers and doctors could reduce the use of potentially harmful medications in people with Alzheimer's disease. Over 11,000 patients living at home who were taking risky drugs like sedatives or antipsychotics were part of the trial. Researchers measured if the mailed information prompted conversations that led to stopping or changing these medications to make care safer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UMass Chan Medical School
Worcester, Massachusetts, 01605, United States
Conditions
Explore the condition pages connected to this study.